Pf-07220060 Monohydrate

6 trials

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

0 Recruiting

6 Completed trials

1 Sponsors

16 Countries

Phase III

Phase II

Phase I/II

Phase I (FiH)

Phase III: 2 Phase II: 2 Phase I/II: 1 Phase I (FiH): 1

Oversight events:

14 temporary halts across 1 trial

View oversight register →

Indications tested

Breast cancer metastatic 2 Breast cancer 1 Non-small cell lung cancer metastatic 1 Liposarcoma metastatic 1 Colorectal cancer metastatic 1 Prostate cancer metastatic 1

Sponsors using this IMP

All trials

6 total

A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, … Ended

2024-512925-95-00 Phase III 16 countries Pfizer Inc.
AN INTERVENTIONAL SAFETY AND EFFICACY PHASE 1B/2, OPEN-LABEL STUDY TO INVESTIGATE TOLERABILITY, PK, AND ANTITUMOR ACTIVITY OF VEPDEGESTRANT … Ended

2023-508130-33-00 Phase I/II 3 countries Pfizer Inc.
A Phase 1b/2 Study of PF-07220060 in Combination with PF-07104091 Plus Endocrine Therapy in Participants with BC and other Advanced Solid Tu… Ended

2023-509504-15-00 Phase II 3 countries Pfizer Inc.
A Phase 1/2a study of PF-07220060 in Participants with Advanced Solid Tumors Ended

2024-512120-11-00 Phase I (FiH) 2 countries Pfizer Inc.
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom… Ended

2024-512848-30-00 Phase II 8 countries Pfizer Inc.
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan… Ended

2023-506487-13-00 Phase III 14 countries Pfizer Inc.

Showing 1–6 of 6 trials

← All drugs A–Z